Diane Hanger

Title: Diane Hanger: Innovator in Tau Phosphorylation Research

Introduction

Diane Hanger is a prominent inventor based in London, GB. She has made significant contributions to the field of biomedical research, particularly in understanding tau phosphorylation and its implications for tauopathies. Her innovative work has led to the development of methods that could potentially transform therapeutic approaches to neurodegenerative diseases.

Latest Patents

Diane Hanger holds a patent titled "Methods for screening for inhibitors of tau phosphorylation by casein kinase I." This patent discloses methods for screening substances capable of modulating the phosphorylation of tau protein, specifically paired helical filament (PHF) tau. The patent outlines the use of these modulators in treating tauopathies. The assays and screening methods are based on identifying new phosphorylation sites in PHF tau and new kinases, particularly casein kinase 1, as therapeutic targets.

Career Highlights

Throughout her career, Diane Hanger has focused on the intricate mechanisms of tau protein phosphorylation. Her research has provided valuable insights into the role of tau in neurodegenerative diseases, paving the way for potential new treatments. Her dedication to advancing scientific knowledge has established her as a respected figure in her field.

Collaborations

Diane has collaborated with notable researchers, including Brian H. Anderton and Malcolm Andrew Ward. These collaborations have further enriched her research and contributed to the advancement of understanding tauopathies.

Conclusion

Diane Hanger's innovative work in tau phosphorylation research exemplifies the impact of scientific inquiry on potential therapeutic advancements. Her contributions continue to inspire future research in the field of neurodegenerative diseases.